Haemonetics HAE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's free cash flow?
- Haemonetics (HAE) reported free cash flow of $53.28M in Q1 2026.
- How has Haemonetics's free cash flow changed year-over-year?
- Haemonetics's free cash flow decreased by 47.2% year-over-year, from $100.91M to $53.28M.
- What is the long-term trend for Haemonetics's free cash flow?
- Over 2 years (2022 to 2026), Haemonetics's free cash flow has grown at a 85.4% compound annual growth rate (CAGR), from $75.75M to $260.44M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.